£134m acquisition opens up European export market
A bio-tech group which has merged with a European animal health company expects the £134m acquisition to boost exports and allow the company to focus on product development.
Animalcare Group completed a reverse takeover of Belgium-based Ecuphar in the summer, which has trebled the size of the business.
In the year to June, just before the Ecuphar deal was agreed, Animalcare's underlying profits rose 12% to £3.6m. Revenues for the same period increased 8% to £15.9m.
York-based Animalcare also revealed six-month figures fo... For the full story register now for free or login below...